The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varela-Calvino, R.
Right arrow Articles by Peakman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varela-Calvino, R.
Right arrow Articles by Peakman, M.
The Journal of Immunology, 2001, 167: 3513-3520.
Copyright © 2001 by The American Association of Immunologists

T Cell Activation by Coxsackievirus B4 Antigens in Type 1 Diabetes Mellitus: Evidence for Selective TCR V{beta} Usage Without Superantigenic Activity1

Ruben Varela-Calvino*, Gianluca Sgarbi*, Lucy R. Wedderburn{dagger}, Colin M. Dayan{ddagger}, Jenny Tremble* and Mark Peakman2,*

* Department of Immunology, Guy’s, King’s and St. Thomas’ School of Medicine, London, United Kingdom; {dagger} Rheumatology Unit, Institute of Child Health, UCL, London, United Kingdom; and {ddagger} Division of Medicine, University of Bristol, Bristol, United Kingdom

Numerous clinical and epidemiological studies link enteroviruses such as the Coxsackie virus group with the autoimmune disease type 1 diabetes mellitus (DM). In addition, there are reports that patients with type 1 DM are characterized by skewing of TCR V{beta} chain selection among peripheral blood and intraislet T lymphocytes. To examine these issues, we analyzed TCR V{beta} chain-specific up-regulation of the early T cell activation marker, CD69, on CD4 T cells after incubation with Coxsackievirus B4 (CVB4) Ags. CD4 T cells bearing the V{beta} chains 2, 7, and 8 were the most frequently activated by CVB4. Up-regulation of CD69 by different TCR families was significantly more frequent in new onset type 1 DM patients (p = 0.04), 100% of whom (n = 8) showed activation of CD4 T cells bearing V{beta}8, compared with 50% of control subjects (n = 8; p = 0.04). T cell proliferation after incubation with CVB4 Ags required live, nonfixed APCs, suggesting that the selective expansion of CD4 T cells with particular V{beta} chains resulted from conventional antigen processing and presentation rather than superantigen activity. Heteroduplex analysis of TCR V{beta} chain usage after CVB4 stimulation indicated a relatively polyclonal, rather than oligo- or monoclonal response to viral Ags. These results provide evidence that new-onset patients with type 1 DM and healthy controls are primed against CVB4, and that CD4 T cell responses to the virus have a selective TCR V{beta} chain usage which is driven by viral Ags rather than a superantigen.




This article has been cited by other articles:


Home page
J. Virol.Home page
R. Varela-Calvino, A. Skowera, S. Arif, and M. Peakman
Identification of a Naturally Processed Cytotoxic CD8 T-Cell Epitope of Coxsackievirus B4, Presented by HLA-A2.1 and Located in the PEVKEK Region of the P2C Nonstructural Protein
J. Virol., December 15, 2004; 78(24): 13399 - 13408.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Varela-Calvino, R. Ellis, G. Sgarbi, C. M. Dayan, and M. Peakman
Characterization of the T-Cell Response to Coxsackievirus B4: Evidence That Effector Memory Cells Predominate in Patients With Type 1 Diabetes
Diabetes, June 1, 2002; 51(6): 1745 - 1753.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.